Survival Following Recanalization of Chronic Total Occlusion: The Devil Is in the Details.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. CTO PCI vs. medical therapy in stable CAD: real-world outcomes from a target trial emulation of SCAAR registry data.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
   Article
2. Application and Delphi Validation of an Omaha System-Based Evaluation Index for Post-PCI Rehabilitation Nursing.Journal of multidisciplinary healthcare · 2026
   Article
3. Chronic Total Occlusion Revascularization Strategies: A Comparative Study of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.Reviews in cardiovascular medicine · 2025
   Article

Corrections and comments

• Comment on
  Chronic Total Occlusion is Not a Risk Factor for Mortality in Patients With Successful Percutaneous Coronary Intervention: A Cohort Study.2023

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as